ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $190,000 | -43.8% | 38,802 | -39.4% | 0.00% | – |
| Q2 2021 | $338,000 | +181.7% | 64,056 | +157.2% | 0.00% | – |
| Q1 2021 | $120,000 | -28.6% | 24,909 | -35.7% | 0.00% | – |
| Q4 2020 | $168,000 | -24.7% | 38,745 | -28.5% | 0.00% | – |
| Q3 2020 | $223,000 | -15.8% | 54,198 | -47.5% | 0.00% | – |
| Q2 2020 | $265,000 | +5.2% | 103,242 | +18.5% | 0.00% | – |
| Q1 2020 | $252,000 | -30.2% | 87,152 | -8.4% | 0.00% | – |
| Q4 2019 | $361,000 | -62.0% | 95,110 | -48.8% | 0.00% | – |
| Q3 2019 | $949,000 | -18.4% | 185,606 | -1.1% | 0.00% | – |
| Q2 2019 | $1,163,000 | +43.2% | 187,586 | +64.2% | 0.00% | – |
| Q1 2019 | $812,000 | -0.2% | 114,242 | +19.9% | 0.00% | – |
| Q4 2018 | $814,000 | -56.2% | 95,292 | +2.7% | 0.00% | – |
| Q3 2018 | $1,857,000 | +159.4% | 92,759 | +234.4% | 0.00% | – |
| Q2 2018 | $716,000 | -85.3% | 27,735 | -86.3% | 0.00% | -100.0% |
| Q1 2018 | $4,855,000 | -29.1% | 203,169 | +0.5% | 0.00% | +100.0% |
| Q4 2017 | $6,849,000 | +15.0% | 202,084 | -28.2% | 0.00% | -50.0% |
| Q3 2017 | $5,958,000 | +498.2% | 281,431 | +394.3% | 0.00% | – |
| Q2 2017 | $996,000 | -6.6% | 56,939 | -6.5% | 0.00% | – |
| Q1 2017 | $1,066,000 | +224.0% | 60,897 | +212.9% | 0.00% | – |
| Q4 2016 | $329,000 | +33.2% | 19,461 | +29.5% | 0.00% | – |
| Q3 2016 | $247,000 | +30.7% | 15,031 | +20.3% | 0.00% | – |
| Q2 2016 | $189,000 | -37.8% | 12,494 | +16.2% | 0.00% | – |
| Q4 2015 | $304,000 | +12.6% | 10,749 | -33.5% | 0.00% | – |
| Q3 2015 | $270,000 | +3.4% | 16,152 | +62.5% | 0.00% | – |
| Q2 2015 | $261,000 | +29.9% | 9,937 | -14.1% | 0.00% | – |
| Q4 2014 | $201,000 | -22.7% | 11,567 | -17.3% | 0.00% | – |
| Q3 2014 | $260,000 | -19.8% | 13,988 | -21.1% | 0.00% | – |
| Q2 2014 | $324,000 | – | 17,729 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |